Martin Daniel C.

CIK 00017528271 companyWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001752827

Recent Transactions

34 trades

Disposition to Issuer
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2024-06-11−38,900→ 0 total
Disposition to Issuer
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2024-06-11−54,667→ 0 total
Disposition from Tender
Deciphera Pharmaceuticals, Inc.
Common Stock
2024-06-11−31,330→ 0 total
Award
Deciphera Pharmaceuticals, Inc.
Common Stock
2024-06-11+20,163→ 75,281 total
Disposition to Issuer
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2024-06-11−44,600→ 0 total
Disposition to Issuer
Deciphera Pharmaceuticals, Inc.
Common Stock
2024-06-11−43,951→ 31,330 total
Disposition to Issuer
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2024-06-11−62,971→ 0 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2024-02-16$15.62/sh−2,267→ 55,118 total
Award
Deciphera Pharmaceuticals, Inc.
Common Stock
2024-02-15+9,725→ 57,385 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2024-02-15+38,900→ 38,900 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2024-01-16$14.47/sh−1,624→ 47,660 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2023-12-13$15.37/sh−1,727→ 49,284 total
Award
Deciphera Pharmaceuticals, Inc.
Common Stock
2023-12-12+5,576→ 51,011 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2023-11-30$12.57/sh−17,801→ 45,435 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2023-10-30$12.02/sh−1,407→ 62,884 total
Award
Deciphera Pharmaceuticals, Inc.
Common Stock
2023-10-28+5,576→ 64,291 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2023-06-16$14.40/sh−1,238→ 58,413 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2023-02-16$15.10/sh−1,159→ 58,381 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2023-02-15+44,600→ 44,600 total
Award
Deciphera Pharmaceuticals, Inc.
Common Stock
2023-02-15+11,151→ 59,540 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2023-01-17$21.24/sh−1,603→ 48,389 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2022-06-16$10.75/sh−1,311→ 49,521 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2022-02-16$9.05/sh−1,146→ 48,668 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2022-01-18+54,667→ 54,667 total
Award
Deciphera Pharmaceuticals, Inc.
Common Stock
2022-01-18+13,667→ 49,814 total
Award
Deciphera Pharmaceuticals, Inc.
Common Stock
2021-12-15+8,300→ 36,147 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2021-12-15+62,971→ 62,971 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-01-22$36.10/sh+26,999→ 43,999 total
Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-01-22−26,999→ 63,001 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-01-22$67.18/sh−26,999→ 17,000 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2019-09-19$35.56/sh−3,000→ 17,000 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2019-01-30+52,000→ 52,000 total
Award
Deciphera Pharmaceuticals, Inc.
Common Stock
2018-09-18+20,000→ 20,000 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2018-09-18+90,000→ 90,000 total

Companies

Deciphera Pharmaceuticals, Inc.
Chief Commercial Officer

Recent Filings

Address

C/O DECIPHERA PHARMACEUTICALS, INC. 500 TOTTEN POND ROAD

WALTHAM, MA, 02451

View on SEC.gov